Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

A kidney transplant patient developed pink skin bumps with spiny centers on her face and limbs.

Tildrakizumab significantly improved psoriasis symptoms and well-being over 52 weeks.

Naproxen can cause serious lung issues, but high-dose aspirin might be safer.

Nilotinib can cause generalized keratosis pilaris.

Oral JAK inhibitors effectively treat alopecia areata and are generally well-tolerated.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Tofacitinib may help treat hair loss in children with alopecia areata.

Both penicillamine and tiopronin have significant side effects, but trying the alternative drug can be beneficial if the first is not tolerated.

Cladribine has known risks and potential new safety concerns, requiring careful monitoring.

Treat active lichen planopilaris early to prevent permanent hair loss.

Ixekizumab effectively treats generalized pustular psoriasis.

Using anthralin and calcipotriene together might help treat tough cases of alopecia areata, but more research is needed to understand how it works.

Monitor for early signs of myelosuppression, like hair loss, in patients on azathioprine to manage side effects.

Clofazimine may be effective for treating ashy dermatosis.

Pimecrolimus cream is not effective for treating alopecia areata.

Diffuse lichen planopilaris greatly reduces quality of life.

A young boy with a rare skin and nail condition improved significantly with simple topical treatments.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

Triamcinolone hexacetonide is effective but has side effects, while PRP and minoxidil are safer alternatives for treating alopecia areata.

Hair thinning is a common but generally mild and reversible side effect of teriflunomide in multiple sclerosis patients.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

Calcipotriol works almost as well as clobetasol for mild to moderate alopecia areata with fewer side effects.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

Topical ruxolitinib may help some skin conditions but needs more research for alopecia areata.